Ferroglycine Sulfate

危険有害性情報のコード(GHS)

• 絵表示(GHS)

  

• 注意喚起語

  Warning

• 危険有害性情報

  H319：強い眼刺激

• 注意書き

  P264：取扱い後は皮膚をよく洗うこと。

  P264：取扱い後は手や顔をよく洗うこと。

  P280：保護手袋/保護衣/保護眼鏡/保護面を着用するこ と。

  P305+P351+P338：眼に入った場合：水で数分間注意深く洗うこと。次にコ ンタクトレンズを着用していて容易に外せる場合は外す こと。その後も洗浄を続けること。

Ferroglycine Sulfate 化学特性,用途語,生産方法

• Originator

  Ferronord,Cooper,US,1956

• 定義

  Iron(II) gluconate (a ferrous gluconate) is used to treat hypochromic anemia. The real problem of iron therapy is not the theoretical utilization of iron, the reticulocyte response, or even the daily increase of hemoglobin. These are important only as they indicate the return of the patients' blood to normal in a reasonably short time without undue inconvenience. Most patients suffering from hypochromic anemia respond well to most forms of iron when administered in adequate dosage. For patients who cannot tolerate the usual iron compounds, it is essential to have a medication that is effective and causes minimum disturbance. Ferrous gluconate is such a medicament.

• Manufacturing Process

  10.0 g of ferrous sulfate and 2.7 g of glycine are thoroughly mixed and carefully heated under nitrogen to 70°C. Reaction occurs rapidly, and the complex compound is obtained as soon as the color turns uniformly lightbrown. After cooling to 20°C, 12.7 g of ferrous sulfate-glycine complex are obtained, which contains 100 mg Fe++-ion sper 0.63 g.

• Therapeutic Function

  Hematinic

Ferroglycine Sulfate 上流と下流の製品情報

Ferroglycine Sulfate 生産企業

Global(16)Suppliers

17169-60-7, Ferroglycine Sulfate キーワード